The development of endoxifen for breast cancer

Research output: Contribution to journalComment/debate

Original languageEnglish (US)
Pages (from-to)102-105
Number of pages4
JournalClinical Advances in Hematology and Oncology
Volume16
Issue number2
StatePublished - Feb 1 2018

Fingerprint

Breast Neoplasms
4-hydroxy-N-desmethyltamoxifen

ASJC Scopus subject areas

  • Hematology
  • Oncology

Cite this

The development of endoxifen for breast cancer. / Goetz, Matthew Philip.

In: Clinical Advances in Hematology and Oncology, Vol. 16, No. 2, 01.02.2018, p. 102-105.

Research output: Contribution to journalComment/debate

@article{9391574d763b430e89dc165b1460c4fb,
title = "The development of endoxifen for breast cancer",
author = "Goetz, {Matthew Philip}",
year = "2018",
month = "2",
day = "1",
language = "English (US)",
volume = "16",
pages = "102--105",
journal = "Clinical Advances in Hematology and Oncology",
issn = "1543-0790",
publisher = "Millennium Medical Publishing, Inc.",
number = "2",

}

TY - JOUR

T1 - The development of endoxifen for breast cancer

AU - Goetz, Matthew Philip

PY - 2018/2/1

Y1 - 2018/2/1

UR - http://www.scopus.com/inward/record.url?scp=85042487169&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85042487169&partnerID=8YFLogxK

M3 - Comment/debate

VL - 16

SP - 102

EP - 105

JO - Clinical Advances in Hematology and Oncology

JF - Clinical Advances in Hematology and Oncology

SN - 1543-0790

IS - 2

ER -